Management Discusses Recent Transformational Changes Undertaken to Drive Shareholder Value
We sat down with CEO Steve Fife and CFO Carl Aure on December 14, 2023, for a fireside chat following our initiation of coverage report, which was published on November 29, 2023. This report contains a transcript of the conversation, which can be accessed on-demand in our full report. Management formally announced its LV360 strategic initiatives in January 2023, and began its implementation in March. This has proven to be a pivotal event, as the company returned to both sales and earnings growth as soon as the June 2023 quarter despite the current challenges in the direct selling channel. Management describes how the wheels of change began turning shortly after Steve Fife was named the permanent CEO in early 2021. There was a need for a significant strategic change in order to break out of the $200-235 million sales channel that the company had been mired in for many years. By the end of 2022, the entire senior leadership team was transformed and LV360 was developed, all the while navigating one of the most difficult operating environments the direct selling channel has faced in recent memory. A strong balance sheet and large free cash flow conversion rates have been particularly beneficial in helping the company manage all of these challenges and changes, including the implementation of a regular dividend in 2022, which was raised a year later, as well as the declaration of a special dividend to return excess cash to shareholders in 2023.LifeVantage is a company focused on biohacking the aging code through nutrigenomics, the study of how nutrition and naturally occurring compounds affect its genes to support good health. The company is engaged in the identification, research, development and distribution of nutraceutical dietary supplements and personal care products, including its scientifically-validated Protandim? line of dietary supplements, LifeVantage? Omega+ and ProBio dietary supplements, TrueScience?, its line of skin and hair care products, Petandim? for Dogs, its companion pet supplement formulated to combat oxidative stress in dogs, Axio?, its Smart Energy Drink mixes, and PhysIQ?, its Smart Weight Management System.
Water Tower Research is built on the foundation of democratizing information flow. We bridge the growing information gap between companies and investors through our investor engagement strategies and open-access research platform.
Our research analysts are Wall Street veterans with the experience and knowledge to work with companies and investors in tandem. We provide access to the information and content that anchors the due diligence process for both professional money managers and individual investors. We leverage traditional research distribution channels and the best of modern digital strategies and tactics to amplify this information flow globally to engage all categories of investors and stakeholders.
Information flow is the foundation for creating investor awareness, knowledge, and engagement. Our mission is to help companies and investors have the tools they need and achieve their goals.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.